CNBC launches initiative to help 30 million Americans with rare diseases
Thirty million. It's a big number. Maybe not in the context of business news, where we typically talk about company…
health care industry
What to expect from the pharmaceutical industry at the JPM conference
Heidi Overton, Novo Nordisk CEO Maziar “Mike” Doustdar, Eli Lilly CEO David Ricks and Commerce Secretary Howard Lutnick listen as…
Abivax Stock Rises to Become Top Biotech Acquisition Target
Europe's best-performing blue-chip stocks in 2025 are expected to be bought by a larger peer, in a deal analysts say…
Patient advocates urge US court to stop AFP's prescription operations
In a photo illustration, prescription medications are seen next to a bottle of pills on July 23, 2024 in New…
CNBC's Becky Quick details her daughter's journey into rare diseases
I've spent the last 25 years in front of the camera here at CNBC and people have come to know…
OpenAI launches ChatGPT Health to connect users' medical records
OpenAI CEO Sam Altman attends an event to introduce AI for enterprise in Tokyo on February 3, 2025. Kim Kyung-hoon…
RFK Jr. Reveals Nutritional Guidelines, Boosting Protein and Less Processed Foods
Health and Human Services Secretary Robert F. Kennedy Jr. speaks during the daily briefing in the Brady Briefing Room of…
Novo Nordisk's first GLP-1 obesity pill launched in the US
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, outside Copenhagen, on November…
These actions will benefit from new habits
The wave is about to become a wave. At this time, there are numerous barriers for people considering treating their…
Eli Lilly investors shouldn't worry that rival Novo Nordisk has the first anti-obesity pill on sale
Jim Cramer says not to worry about Novo Nordisk's lead over Club that has Eli Lilly in the obesity pill…